Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
140 participants
INTERVENTIONAL
2012-08-31
2015-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Is the Cough Stress Test Equivalent to the 24 Hour Pad Test in the Assessment of Stress Incontinence?
NCT01123096
Second-generation Radiofrequency Application and Therapeutic Exercise for Stress Urinary Incontinence
NCT07095283
Identifying Stress Urinary Incontinence in Women With Pelvic Organ Prolapse
NCT03005977
Urodynamics: Prone Vs. Seated Position
NCT06864117
Age-stratified Outcome of Pelvic Floor Muscle Exercise for Urinary Incontinence
NCT01445834
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
During the initial appointment with the study coordinator, patients will be randomized to 4 groups (A, B, C, and D). Patients in group A will be scheduled to undergo Cough Stress Test (CST) with a comfortably full bladder. This will be subjectively reported by the patient. Patients in group B will be scheduled to undergo CST with an empty bladder after straight catheterization. Group C patients will be scheduled to undergo CST with a bladder infused with 200 cc of saline. Patients in group D will be scheduled to undergo CST with the bladder filled to half functional capacity as determined from the largest voided volume recorded in the patient's voiding diary. CST will be performed in the standing and sitting position for each patient in each of the above groups. The sequence of performing the standing and sitting CST will be randomly assigned for each patient.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
Cough Stress Test with a comfortably full bladder.
Cough Stress Test
Varying bladder volumes during cough stress test.
Group B
Cough Stress Test with an empty bladder after straight catheterization.
Cough Stress Test
Varying bladder volumes during cough stress test.
Group C
Cough Stress Test with a bladder infused with 200 cc of saline.
Cough Stress Test
Varying bladder volumes during cough stress test.
Group D
Cough Stress Test with the bladder filled to half functional capacity as determined from the largest voided volume recorded in the patient's voiding diary.
Cough Stress Test
Varying bladder volumes during cough stress test.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cough Stress Test
Varying bladder volumes during cough stress test.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* any other clinical diagnosis other than urinary incontinence who undergo UDS testing ( e.g. interstitial cystitis, overactive bladder dry, bladder outlet obstruction)
* were taking alpha agonists or anticholinergic medications within 2 weeks of the testing
* had an elevated Post Void Residual (PVR) \>50cc
* any physical or mental disability that would either not allow participation or impede the ability to give fully informed consent
* pregnancy
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospitals Cleveland Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joseph Henderson
MD
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
07-11-37
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.